Insider Selling: DocuSign, Inc. (NASDAQ:DOCU) CEO Sells 7,911 Shares of Stock

DocuSign, Inc. (NASDAQ:DOCUGet Free Report) CEO Allan C. Thygesen sold 7,911 shares of the business’s stock in a transaction dated Monday, July 1st. The shares were sold at an average price of $53.77, for a total value of $425,374.47. Following the sale, the chief executive officer now owns 117,643 shares of the company’s stock, valued at $6,325,664.11. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

DocuSign Stock Down 1.5 %

NASDAQ DOCU traded down $0.82 during trading hours on Tuesday, reaching $54.32. The company’s stock had a trading volume of 2,352,753 shares, compared to its average volume of 2,987,936. The firm’s 50-day moving average price is $55.59 and its 200-day moving average price is $56.71. DocuSign, Inc. has a 1 year low of $38.11 and a 1 year high of $64.76. The company has a market capitalization of $11.12 billion, a price-to-earnings ratio of 104.46, a PEG ratio of 4.45 and a beta of 0.94.

DocuSign (NASDAQ:DOCUGet Free Report) last posted its quarterly earnings results on Thursday, June 6th. The company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.09. DocuSign had a return on equity of 15.44% and a net margin of 3.81%. The company had revenue of $709.64 million for the quarter, compared to analysts’ expectations of $706.07 million. Equities research analysts anticipate that DocuSign, Inc. will post 0.88 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on DOCU shares. Citigroup cut their price target on DocuSign from $93.00 to $86.00 and set a “buy” rating for the company in a research note on Wednesday, June 5th. Piper Sandler cut their price objective on DocuSign from $65.00 to $60.00 and set a “neutral” rating for the company in a research note on Friday, June 7th. JMP Securities reiterated a “market outperform” rating and set a $84.00 price objective on shares of DocuSign in a research note on Friday, June 7th. UBS Group upgraded DocuSign from a “sell” rating to a “neutral” rating and boosted their price objective for the company from $48.00 to $62.00 in a research note on Friday, April 12th. Finally, Royal Bank of Canada cut their price objective on DocuSign from $59.00 to $52.00 and set a “sector perform” rating for the company in a research note on Friday, June 7th. Two investment analysts have rated the stock with a sell rating, eight have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $59.36.

Get Our Latest Analysis on DocuSign

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. LPL Financial LLC raised its holdings in shares of DocuSign by 2.1% during the 3rd quarter. LPL Financial LLC now owns 211,200 shares of the company’s stock worth $8,870,000 after acquiring an additional 4,262 shares in the last quarter. O Shaughnessy Asset Management LLC raised its holdings in shares of DocuSign by 13.6% during the 3rd quarter. O Shaughnessy Asset Management LLC now owns 8,106 shares of the company’s stock worth $340,000 after acquiring an additional 973 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in shares of DocuSign by 712.8% during the 3rd quarter. Tower Research Capital LLC TRC now owns 8,868 shares of the company’s stock worth $372,000 after acquiring an additional 7,777 shares in the last quarter. Schonfeld Strategic Advisors LLC purchased a new stake in shares of DocuSign during the 3rd quarter worth approximately $1,021,000. Finally, Lido Advisors LLC raised its holdings in shares of DocuSign by 12.3% during the 3rd quarter. Lido Advisors LLC now owns 5,264 shares of the company’s stock worth $221,000 after acquiring an additional 575 shares in the last quarter. 77.64% of the stock is owned by hedge funds and other institutional investors.

About DocuSign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Insider Buying and Selling by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.